Searchable abstracts of presentations at key conferences in endocrinology
ISSN 1470-3947 (print)
| ISSN 1479-6848 (online)
Endocrine Abstracts
Menu
Search
Issues/Conferences
Cite
About
Our Services
Policies
Contact
Disclaimer
Search
Issues/Conferences
Cite
About
Our Services
Policies
Contact
Disclaimer
Previous issue
|
Volume 11
|
ECE2006
|
Next issue
8th European Congress of Endocrinology incorporating the British Endocrine Societies
All volumes
0089 NANETS2022
0088 BES2022
0087 UKINETS2022
0086 SFEBES2022
0085 BSPED2022
0084 ETA2022
0083 EYES2022
0082 SFEEU2022
0081 ECE2022
0080 UKINETS2021
0079 BES2021
0078 BSPED2021
0077 SFEBES2021
0076 CHD2021
0075 EYES2021
0074 SFENCC2021
0073 ECE2021
0072 UKINETS2020
0071 BES2020
0070 ECE2020
0069 SFENCC2020
0068 UKINETS2019
0067 EYES2019
0066 BSPED2019
0065 SFEBES2019
0064 BES2019
0063 ECE2019
0062 EU2019
0061 OU2019
0060 UKINETS2018
0059 SFEBES2018
0058 BSPED2018
0057 BES2018
0056 ECE2018
0055 SFEEU2018
0054 NuclearReceptors2018
0053 OU2018
0052 UKINETS2017
0051 BSPED2017
0050 SFEBES2017
0049 ECE2017
0048 SFEEU2017
0047 Theranostics2016
0046 UKINETS2016
0045 BSPED2016
0044 SFEBES2016
0043 WCTD2016
0042 Androgens2016
0041 ECE2016
0040 ESEBEC2016
0039 BSPED2015
0038 SFEBES2015
0037 ECE2015
0036 BSPED2014
0035 ECE2014
0034 SFEBES2014
0033 BSPED2013
0032 ECE2013
0031 SFEBES2013
0030 BSPED2012
0029 ICEECE2012
0028 SFEBES2012
0027 BSPED2011
0026 ECE2011
0025 SFEBES2011
0024 BSPED2010
0023 BSPED2009
0022 ECE2010
0021 SFEBES2009
0020 ECE2009
0019 SFEBES2009
0018 MES2008
0017 BSPED2008
0016 ECE2008
0015 SFEBES2008
0014 ECE2007
0013 SFEBES2007
0012 SFE2006
0011 ECE2006
0010 SFE2005
0009 BES2005
0008 SFE2004
0007 BES2004
0006 SFE2003
0005 BES2003
0004 SFE2002
0003 BES2002
0002 SFE2001
Summary
Abstract Book
Abstracts
Contents
Plenary Lecturers’ Biographical Notes
European Journal of Endocrinology Prize Lecture
European Journal of Endocrinology Abstract
ea0011s1
Geoffrey Harris Prize Lecture
A tale of modern endocrinology
ea0011s2
Transatlantic Medal Lecture
Nuclear receptors and transcriptional control of lipid metabolism
ea0011s3
Clinical Endocrinology Trust Visiting Professor Lecture
Understanding the genetic control of puberty in the human
ea0011s4
British Thyroid Association Pitt-Rivers Lecture
Neurological abnormalities in mice with a dominant negative thyroid hormone alpha 1
ea0011s5
Society for Endocrinology Dale Medal Lecture
The actions of inhibin in endocrine tissues
ea0011s6
Clinical Endocrinology Trust Lecture
Thyroid disease paradigms and problems
ea0011s7
Vitamin D action
Vitamin D action
ea0011s8
Psychological determinants of metabolic risk
Rhabdomyolysis and other adverse effects of statins: what happens when we inhibit HMG CoA reductase
ea0011s9
Embryonic stem cells
Stem cells: regeneration in type 1 diabetes
ea0011s10
Symposia
Thyroid and the heart
Cardiac repercussions of thyroid hormones
ea0011s11
The assessment of cardiovascular risk factors in thyroid disease
ea0011s12
Iodothyronamines: rapid-acting thyroid hormone metabolites
ea0011s13
Role of thyroid hormone receptor isoforms in development and function of heart and other tissues
ea0011s14
The endocrinology of psychiatric disease
Glucocorticoids, enzymes and memory impairments with ageing
ea0011s15
Effects of hypothyroidism on brain metabolism and its associations with neuropsychiatric impairments
ea0011s16
Overview of neuroendocrine side-effects
ea0011s17
Endocrinology of post traumatic stress
ea0011s18
Cancer and the skeleton
Mechanisms of malignant hypercalcaemia
ea0011s19
Hypercalcaemia of malignancy
ea0011s20
Oncogenic osteomalacia: novel insights into the regulation of phosphate homeostasis
ea0011s21
Why does thyroid carcinoma metastasise to bone?
ea0011s22
Cannabinoid signalling
Cannabinoids as modulators of neuroendocrine signaling
ea0011s23
Cannabinoids and feeding behaviour
ea0011s24
ea0011s25
Novel peptides in reproduction
The Kisspeptin-GPR54 axis in reproduction
ea0011s26
Use of recombinant leptin in women with hypothalamic amenorrhea
ea0011s27
A genomic analysis of polypeptide ligands and receptors: the example of relaxin and LGR families
ea0011s28
Novel recombinant gonadotropin molecules in human reproductive dysfunction
ea0011s29
Flies, worms and fish: use in endocrine research
ea0011s30
Dietary restriction and altered insulin/Igf1 signalling: conserved mechanisms regulating lifespan in worms, flies and rodents
ea0011s31
Giant flies and more: probing the functions and genetics of insulin signalling in
Drosophila
ea0011s32
Specifying the cellular responses to IGF signalling by IGF binding proteins: new lessons from the zebrafish model
ea0011s33
Clinical lessons from novel aspects of G protein-coupled receptors signalling
How the pattern of GPCR co-expression can regulate function
ea0011s34
Alpha- and beta-adrenoceptor dysfunction
ea0011s35
Moleular pathology of the FSH receptor
ea0011s36
Therapeutic implications from new aspects in V2 vasopressin receptor dysfunction
ea0011s37
Stromal cell-matrix interactions
Role of heparan sulphates in neuronal stem cell differentiation
ea0011s38
Hormonal regulation of mesenchymal stem cell differentiation in bone
ea0011s39
Cell-adhesion molecules and osteoclast function
ea0011s40
Wnt signalling in the stem cell niche
ea0011s41
Controversies in male health
Does andropause exist?
ea0011s42
Cardiovascular effects of androgens
ea0011s43
Endocrine regulation of prostatic growth
ea0011s44
Stem cell therapeutic approaches to male infertility
ea0011s45
How hormones get into cells
Specific thyroid hormone transporters
ea0011s46
The spectrum of MCT8 gene mutations
ea0011s47
Multidrug resistance P-glycoprotein (mdr-1) excluding corticosteroids from brain
ea0011s48
Cell surface carrier - mediated transport of steroid hormones
ea0011s49
Endocrinology in the foetus
Maternal thyroid function and cognitive impairment in childhood
ea0011s50
Molecular basis of programming of renin-secreting cells
ea0011s51
Birth weight and later disease: genes and maternal diabetes
ea0011s52
Endocrine therapy of the fetus
ea0011s53
Monogenic disorders illuminate metabolic disease
Epidemic obesity in humans
ea0011s54
Specific metabolic features in Prader-Labhart-Willi syndome (PWS) as indicators of the underlying genetic defect
ea0011s55
PPAR gamma and human metabolic disease
ea0011s56
Learning from monogenic diabetes: insights into the fetal and adult beta-cell
ea0011s57
Steroid hormone receptors
The ups and downs of nuclear receptor action in fat and fertility
ea0011s58
Chromatin remodeling
ea0011s59
Cell membrane receptors of steroid hormones
ea0011s60
Lysine modifications in transcriptional regulation by steroid receptors
ea0011s61
Anabolic hormones in sport
Overview of anabolic steroids in sport
ea0011s62
Detecting growth hormone abuse in athletes
ea0011s63
Gene doping: will the age of gene therapy usher in the age of genetic enhancement?
ea0011s64
Erythropoietin
ea0011s65
Disorders of melanocortin receptor functions
MC1R variants: Mendle is quite complex enough
ea0011s66
Identification of the genes causing ACTH insensitivity
ea0011s67
Melanocortin receptor mutations in humans
ea0011s68
Gs-independent signalling of melanocortin-4 receptors
ea0011s69
Endocrine oncogenesis and management of hereditary endocrine tumours
RET function and dysfunction
ea0011s70
Novel management strategies in medullary carcinoma of the thyroid
ea0011s71
Hypoxia inducible factor (HIF) and phaeochromocytoma
ea0011s72
Familial phaeochromocytomas
ea0011s73
Green over-the-counter endocrinology
ea0011s74
Regulation of steroid receptor expression and proliferation in prostate cancer by genistein and other flavonoids
ea0011s75
Soy, flavonoids and osteoporosis
ea0011s76
Aftermath of WHI: the risks or benefits of red clover and soy extracts in postmenopausal OTC HRT
ea0011s77
Management of complex genital anomalies and the transition from childhood to adulthood
Management of the infant with ambiguous external genitalia. The pediatric endocrinologists approach
ea0011s78
Surgical management of ambiguous genitalia in the infant
ea0011s79
Management of complex genital anomalies and the transition from childhood to adulthood: A patients perspective
ea0011s80
Management of Graves' ophthalmopathy
Prevention of thyroid eye disease
ea0011s81
Medical treatment
ea0011s82
Alternative immunomodulatory therapies for Graves ophthalmopathy
ea0011s83
Ophthalmic management of thyroid eye disease
ea0011s84
In vivo
imaging of signalling
OPT: a novel wholemount imaging technology for visualising gene & protein expression
ea0011s85
A mouse reporting on estrogen receptor (ER) transcriptional activity to understand the complexities of female physiology in mammals
ea0011s86
Micro PET-ing in mice
ea0011s87
Contrasting practices in European endocrinology
Diagnosis of hypercortisolism
ea0011s88
Diagnosis of hypercortisolism
ea0011s89
New endocrinology medicines: when are they good value?
ea0011s90
Contrasting expenditure on expensive endocrine therapies e.g. growth hormone
ea0011s91
Contrasting practices in European endocrinology radio-iodine therapy
ea0011s92
Contrasting practices in European endocrinology. Radioiodine therapy. A Danish view
ea0011s93
Research management workshop
ea0011s94
ea0011s95
Funding for commercialisation of research after the biotech bubble
ea0011s96
Nurses Session
Metabolic syndrome
Leptin expands function
ea0011s97
Ghrelin update
ea0011s98
Insulin resistance and type 2 diabetes insights from the study of extreme human phenotypes
ea0011s99
Metabolic syndrome
ea0011s100
Nurse-led weight management: the Counterweight Programme
ea0011s101
Young Endocrinologists Session
Presenting your research – getting your work known
Giving talks
ea0011s102
Practical tips for a perfect poster
ea0011s103
Papers for peer reviewed journals
ea0011s104
PhD/MD Thesis: a recipe for success
ea0011s105
Talking to a lay audience
ea0011s106
Oral Communications
Signal transduction OC1 Novartis Oncology Young Investigator Award
Stress response after TIF-2 disruption: loss of grip on feedback control or adrenocortical impairment?
ea0011oc1
Signalling and internalisation characteristics of corticotropin-releasing hormone (CRH) receptors
ea0011oc2
Activation of cAMP (cAMP) binding protein (CREB) by gonadotrophin-releasing hormone (GnRH) requires calcium influx and PKC activity in gonadotroph cell lines
ea0011oc3
The role of MRAP in the functional expression of the melanocortin 2 receptor
ea0011oc4
The overexpression Pit-1 pathway, switch on by RET, get into apoptosis fate
ea0011oc5
Activation of androgen membrane binding sites induce potent regression of prostate cancer cells
in vitro
and
in vivo
ea0011oc6
The effect of bone marrow stem cell (BMSC) differentiation on growth hormone receptor (GHR)-associated signalling pathways
ea0011oc7
Role of the calcium-calmodulin dependent kinase II in oncogenic Ras-induced proliferation
ea0011oc8
Steroids and reproductive endocrinology
11β-HSD1: anti-inflammatory mechanism in acute and chronic inflammation?
ea0011oc9
Progesterone signaling in human myometrium is mediated through two novel membrane G protein coupled receptors
ea0011oc10
The adrenal X-zone is involved in progesterone inactivation
ea0011oc11
Expression profiling of genes in the testis of rhesus macaques during development and aging
ea0011oc12
Anti-Müllerian hormone (AMH) production by granulosa cells from anovulatory PCO is 100 times higher than from normal ovaries, but is inhibited by metformin
ea0011oc13
Endometrial intracrinology: Expression of 3β-hydroxysteroid dehydrogenase (3βHSD), and 17β-hydroxysteroid dehydrogenase type 5 (17βHSD-5)
ea0011oc14
Role of the Hu proteins, HuR and HuD, and αCP1 in the regulation of androgen receptor expression and activity in prostate cancer cells
ea0011oc15
17β-estradiol regulates pituitary AnxA1 expression and externalization
in vivo
and
in vitro
ea0011oc16
Clinical endocrinology
Copeptin, a precursor of vasopressin, in critically ill patients an observational study
ea0011oc17
Endoscope-assisted pituitary surgery for functioning and non-functioning pituitary adenomas. The experience of the first 80 patients in a single centre
ea0011oc18
Disease remission in long term treated acromegalic patients after somatostatin analog withdrawal
ea0011oc19
A European prospective real-life observational study of Quality of Life in patients with acromegaly
ea0011oc20
Adjuvant radiation therapy of the tumor bed prevents local recurrences in adrenocortical carcinoma
ea0011oc21
Detection of phaeochromocytoma: The emerging role of plasma metanephrines
ea0011oc22
Improved Prognosis in Midgut Carcinoid patients by treating raised circulating Neurokinin A (NKA)
ea0011oc23
Low testosterone and atherogenic lipid profile in aging men
ea0011oc24
Diabetes and metabolism
Cannabinoids increase AMP-activated protein kinase (AMPK) enzyme activity in the hypothalamus and heart via different signalling pathways studies in CB1 knockout animals
ea0011oc25
Neuropeptide S is a novel peptide which potently stimulates the hypothalamo-pituitary-adrenal axis and inhibits food intake
ea0011oc26
A selective increase in adipose 11β-HSD1 expression in corticosterone-treated
Pomc
null mice is associated with development of metabolic syndrome
ea0011oc27
11β-Hydroxysteroid dehydrogenase type 1 oxo-reductase activity is increased in patients with alcoholic chronic liver disease: the key to the phenotype of the alcoholic pseudo-Cushings state?
ea0011oc28
A choline deficient diet in mice prevents high fat diet induced insulin resistance in spite of more severe fatty liver disease
ea0011oc29
The release of the adipocytokine visfatin is regulated by glucose and insulin
ea0011oc30
Comparative analysis of the effects of dehydroepiandrosterone (DHEA) on white and brown pre-adipocyte proliferation/differentiation
ea0011oc31
The
in vitro
effects of resistin on the innate immune signalling pathway in isolated human subcutaneous adipocytes.
ea0011oc32
Neuroendocrinology and neoplasia
Efect of overexpression of GH secretagogue receptor (GHSR) in the pituitary of transgenic mice
ea0011oc33
Transgenic mice overexpressing Urocortin 3 show increased anxiety- and depressive-like behaviours but a hyporesponsive ACTH response to stress
ea0011oc34
Immunocytochemical colocalisation of hormones in the human fetal pituitary
ea0011oc35
Somatostatin analogues in the treatment of acromegaly: correlation between somatostatin receptor subtype expression levels and clinical response
ea0011oc36
90Y-DOTATATE in the treatment of neuroendocrine tumours
ea0011oc37
Germline mutations in patients with apparently sporadic pheochromocytomas/paragangliomas
ea0011oc38
11 beta hydroxysteroid dehydrogense modulation of HPA function importance of genetic background
ea0011oc39
Expression of IGF-I & IGF-IR in tamoxifen sensitive and tamoxifen resistant breast cancer
ea0011oc40
Endocrine genetics
Mutations in Cullin 7, a cofactor for Ubiquitination, cause the 3M intra-uterine growth retardation syndrome
ea0011oc41
Linkage of a fourth gene for familial glucocorticoid deficiency to chromosome 13q
ea0011oc42
Mutation screening of SLC26A4 (PDS) gene in patients with Pendred syndrome and nonsyndromic enlarged vestibular aqueduct
ea0011oc43
Functional impact of polymorphic variation in the gene encoding 11β-hydroxylase (CYP11B1): reduced adrenal 11-hydroxylase efficiency identifies a key intermediate phenotype in hypertension
ea0011oc44
Genotype/phenotype correlation of
PRKAR1A
mutations in patients with Carney complex (CNC) and/or sporadic primary pigmented nodular adrenocortical disease (PPNAD) from the CNC network
ea0011oc45
Predictors and prevalence of paraganglioma syndrome associated with mutations of the
SDHC
-gene
ea0011oc46
Frequent involvement of BMP15 gene variants in women with premature ovarian failure
ea0011oc47
Progressive osseous heteroplasia: a phenotype associated with mutations of the
GNAS1
gene
ea0011oc48
Calcium and bone OC49 Novartis Oncology Young Investigator Award
The A990G polymorphism of calcium sensing receptor gene (CASR) is associated with nephrolithiasis in patients with primary hyperparathyroidism (PHPT)
ea0011oc49
Congenitally hypothyroid mice with (Pax8
−/−
) or without (hyt/hyt) functional TSH receptors (TSHR) display equivalent skeletal phenotypes
ea0011oc50
TSH receptor action in osteoblasts and osteoclasts
in vitro
ea0011oc51
In acromegaly bone mineral density depends on gonadal function
ea0011oc52
Bone involvement in patients with adrenal incidentalomas: role of subclinical hypercortisolism
ea0011oc53
Adult mice harbouring a dominant negative R384C mutation of TRalpha1 have a marked increase in trabecular bone and micro-mineralisation density
ea0011oc54
Thyroid hormones stimulate osteoblast differentiation but inhibit mineralization of bone nodules
in vitro
ea0011oc55
The Scandinavian investigation of primary hyperparathyroidism (pHPT) end of inclusion and preliminary results
ea0011oc56
ThyroidOC57 British Thyroid Association Award
Treatment of experimental hyperthyroid Graves disease with decoy TNF-family ligand receptors, suggests an essential role for BAFF in production of thyroid stimulating antibodies
ea0011oc57
Interleukin 1: the optimal cytokine target in thyroid associated ophthalmopathy?
ea0011oc58
Tri-iodothyronine improves haemodynamic performance and is associated with improved myocardial protection post on-pump coronary artery bypass grafting
ea0011oc59
4-methylbenzylidene-camphor (4MBC) causes pituitary effects comparable to hypothyroidism
ea0011oc60
Phosphodiesterase-resistant PKA I agonists inhibit thyroid cancer cell growth
ea0011oc61
The role of the thyroid hormone transporter monocarboxylate transporter 8 (MCT8) in fetal brain development
ea0011oc62
Gender-specific differences in the expression of deiodinase I (Dio1) in mammals
ea0011oc63
Thyroid hormone receptor TRβ1 mediates Akt activation by T3 in pancreatic β cells
ea0011oc64
Poster Presentations
Bone
An audit of the role of Sestimibi imaging of the parathyroid glands in the management of parathyroid disease
ea0011p1
Does adrenal function influence bone status in primary hyperparathyroidism? Preliminary results in a large series of patients at the time of the diagnosis
ea0011p2
The effect of local radiotherapy on osteoprotegrin levels in patients with bone metastases
ea0011p3
Clinical aspects of diabetic osteoarthropathy in type 1 and type 2 diabetes mellitus patients
ea0011p4
Osteoporotic fractures in old subjects: role of functional and nutritional status and therapy effects during one year after fracture
ea0011p5
Circulating osteoprotegerin and receptor activator of NF- κB ligand system in patients with beta-thalassemia major
ea0011p6
The role of genetic individuality and phytoestrogens with minerals in prevention and treatment of Postmenopausal osteoporosis
ea0011p7
Is there any combined influence of the N363S polymorphism in the glucocorticoid receptor gene and the BsmI polymorphism in the vitamin D receptor gene on the occurrence of glucocorticoid-induced osteoporosis in patients with bronchial asthma?
ea0011p8
Bone mineral density in patients with type 1 diabetes
ea0011p9
Thyroid hormone receptor alpha has a critical negative role in maintenance of the adult skeleton
ea0011p10
PTH and phosphate circadian rhythms are altered in adult growth hormone deficient patients with low bone mineral density
ea0011p11
Oral phosphate therapy used as an adjunct to growth hormone in adult growth hormone deficiency results in greater changes in bone mineral density compared with growth hormone replacement alone
ea0011p12
Polymorphism in farnesil pirofosfato sintasi (FDPS) gene and relation with bone mineral density and response to aminobisfosfonate treatment
ea0011p13
Do different generations of PTH assay induce different diagnosis in renal bone disease?
ea0011p14
Management of primary hyperparathyroidism are we following consensus guidelines?
ea0011p15
Value of qualitative bone histology assessment in the evaluation of subjects with primary osteoporosis
ea0011p16
Hearing impairment increases risk of bone fractures in women with Turners syndome
ea0011p17
Evaluation of bone mineral density and markers of bone turnover in haemodialysis patients
ea0011p18
The effect of ceramide on IGF-1 induced proliferation in growth plate chondrocytes
ea0011p19
Treatment and follow up of primary hyperparathyroidism: 50 cases
ea0011p20
Is there any relationship between the BsmI and FokI polymorphisms in the vitamin d receptor gene and bone mineral density in men?
ea0011p21
Mutational Analysis of the PHEX gene in familial and sporadic cases of X-linked hypophosphatemia (XLH)
ea0011p22
The reduction of bone mineral density in post-menopausal women with primary hyperparathyroidism is higher in the presence of concomitant GH hormone secretion impairment
ea0011p23
Effect of melatonin on gene expression and mineralization in mouse osteoblast culture
ea0011p24
Effects of growth hormone administration on parathyroid hormone sensitivity and bone mineral metabolism in established osteoporosis
ea0011p25
Is 1 g of calcium and 800 IU of Vitamin D sufficient to replenish Vitamin D stores in postmenopausal women with low bone density?
ea0011p26
Synergistic induction of osteoblastic local glucocorticoid metabolism by inflammatory cytokines and glucocorticoids: a novel mechanism for glucocorticoid-induced bone disease
ea0011p27
Evidence for high prevalence of hormonal irregularities in male osteoporosis
ea0011p28
Evaluation of bone markers and structure in subclinical Cushings syndrome
ea0011p29
Asymptomatic primary hyperparathyroidism: preliminary results of a prospetive randomized study on the effect of parathyroidectomy
ea0011p30
Brown tumors in a patient with gluten enteropathy and masked primary (or tertiary) hyperparathyroidism
ea0011p31
Baseline characteristics of postmenopausal Greek women with osteoporosis who had inadequate clinical response to antiresorptive medications.
ea0011p32
Effect of grape procyanidins on TNF alpha mRNA expression and cell DNA damage in MC3T3-E1 osteoblast-like cells
in vitro
ea0011p33
The effects of Dexamethasone and Dehydroepiandrosterone (DHEA) on cytokines and receptor expression in a human osteoblastic cell line: potential steroid-sparing role for DHEA
ea0011p34
Assessment of bone health and body composition in Glasgow school children
ea0011p35
Assessment of bone mineral density (BMD) in patients with adrenal incidentaloma (ai): comparison between dual-energy x-ray absorptiometry (DEXA) and quantitative ultrasonometry (QUS)
ea0011p36
A comparative study of neck ultrasonography, sestamibi scan and parathyroid surgery findings
ea0011p37
Glucocorticoid metabolism in mouse osteoblasts: a model for the effects of local glucocorticoid generation on bone
ea0011p38
Long-term growth hormone (GH) replacement in GH deficient adults favourable effect on bone and body composition
ea0011p39
Does parathyroidectomy reduce the risk of fractures and renal stones? Results of a systematic review and meta analysis
ea0011p40
Brown tumors in hyperparathyroidism may be mistaken for primitive bone neoplasia: report of two cases
ea0011p41
The effect of once-weekly Risedronate on biochemical markers of bone turnover after three month of treatment
ea0011p42
Quantitative ultrasound at the hand phalanges in patients with acromegaly
ea0011p43
Selenium supplementation restores the antioxidative capacity and prevents cell damage in mesenchymal stem cells
in vitro
ea0011p44
Expression of the membrane-associated hormone-sensitive protein UO-44 in hMSC-TERT immortalized mesenchymal stem cells
ea0011p45
The effect of once-weekly Risedronate on biochemical markers of bone turnover after three month of treatment
ea0011p46
Clinical case reports
Forced conservative management of a patient with pituitary tumour apoplexy and reduced conscious level
ea0011p47
An unusual presentation of fits
ea0011p48
An unusual cause of confusion
ea0011p49
Recurrent congenital neonatal hyperthyroidism in a mother with Graves disease (post radio-ablation) on thyroxine replacement
ea0011p50
Isolated ACTH deficiency following long-term benzodiazepine treatment
ea0011p51
Infertility and bilateral testicular masses due to 21-hydroxylase deficiency
ea0011p52
Graves eye disease developing following radioiodine treatment for toxic nodular goitre
ea0011p53
Recurrent hypoglycaemia: an unusual association of islet cell hyperplasia and coeliac disease
ea0011p54
Screening of osteoporosis in a small Romanian town
ea0011p55
Acute myocardial infarction and Graves thyrotoxicosis
ea0011p56
Acromegaly, pregnancy and diabetes mellitus a successful maternal and foetal outcome
ea0011p57
Surgical management of metastatic phaeochromocytoma: review of 2 cases
ea0011p58
The coincidence of mucoepidermoid and papillary thyroid carcinoma. A case report
ea0011p59
DIre Straits
- hypothalamic diabetes insipidus, acute myeloid leukaemia and high risk cytogenetics: 45,XX,t(3;3)(q21q26),-7
ea0011p60
Metastatic insulinoma or not?
ea0011p61
APECED (Autoimmune PolyEndocrinopathy-Candidiasis-Ectodermal Dystrophy) syndrome with atypical or incomplete presentation: report of 4 cases with AIRE mutations in heterozygosity
ea0011p62
Relationship between age of onset, natural course and therapeutic approach in patients with acromegaly
ea0011p63
Sweets syndrome and thyroid diseases: is there a link?
ea0011p64
Bone marrow aplasia in a patient with panhypopituitarism responsive to sex hormone therapy. The importance of compliance with testoterone therapy
ea0011p65
Multiple endocrine neoplasia type 1 (MEN1) in a patient with systemic mastocytosis
ea0011p66
Brown tumour of the maxilla as the presenting feature of parathyroid carcinoma
ea0011p67
Unexpected detection of thyroid cancer in a patient with presumed Graves thyrotoxicosis
ea0011p68
Primary hyperparathyroidism (PHPT): Still a cause of hypertension resistant to therapy
ea0011p69
Spontaneous pregnancy after trans-spenoidal surgery in a patient with pituitary hypophysitis a case report
ea0011p70
Adipsic diabetes insipidus following pituitary surgery for a macroprolactinoma
ea0011p71
Regression of somatotropinoma in the course of treatment with octreotide in a female patient with acromegaly
ea0011p72
Familial hyperparathyroidism with a mutation in the HRPT2 gene
ea0011p73
Pendreds syndrome with three mutations
ea0011p74
About three cases of Riedel thyroiditis
ea0011p75
Parathyroid carcinoma in a patient with chronic renal failure on long-term dialysis
ea0011p76
Should prophylactic thyroidectomy be carried out in mucosal neuroma syndrome?
ea0011p77
Synchronous malignant para-aortic phaeochromocytoma and vagal nerve paraganglioma in a patient with germline SDHB mutation
ea0011p78
Ophthalmic presentations of Cushings syndrome
ea0011p79
Long-term outcome of untreated Cushings syndrome due to pituitary microadenoma
ea0011p80
Invasive prolactinoma with multiple recurrences: pituitary atypical adenoma or pituitary carcinoma? Report of a case
ea0011p81
A case of primary pigmented micronodular hyperplasia as a cause of Cushing syndrome
ea0011p82
Endocrine evaluation in a man with restrictive eating behaviour
ea0011p83
Hypopituitarism in an adult thalassemic patient. Effects of different replacement therapies
ea0011p84
Langerhans cell histiocytosis: management dilemma for the adult endocrinologist!
ea0011p85
A case of bacterial endocarditis in a patient with acromegaly
ea0011p86
Gitelmans syndrome in pregnant, type 1 diabetic patient presented with foetal growth retardation, and bilateral hydronephrosis and hydroureter
ea0011p87
The prolonged progressive course of acromegaly, complicated with diabetes mellitus, bilateral gonarthropathy, thyroid pathology and severe papillomatosis (clinical observation)
ea0011p88
A case of adult GH deficit in a woman with Autoimmune Polyendocrine Syndrome type II
ea0011p89
Spontaneous thrombosis of ophthalmic artery aneurysm causing isolated cortisol deficiency
ea0011p90
Aortic involvement in Turner syndrome
ea0011p91
Purely adrenaline-secreting phaeochromocytoma: a classical presentation of a rare entity
ea0011p92
A scary awakening acute paralysis in a young man
ea0011p93
Systemic amyloidosis presenting with thyrotoxicosis: a case report
ea0011p94
Unusual case of Pseudohypoparathyroidism type Ib
ea0011p95
A case of Cushings syndrome and rapid course of illness
ea0011p96
Primary adrenal insufficiency, gonadal failure and weak legs
ea0011p97
Hypocalcemic cardiomyopathy in a patient with primary hypoparathyroidism and Fahrs disease
ea0011p98
An unusual case of panhypopituitarism associated with positive ANCA: atypical presentation of Wegeners disease or lymphocytic hypophysitis?
ea0011p99
Isolated secondary hypothyroidism in identical twins
ea0011p100
Adrenal-insufficiency manifesting as hyperkalaemic paralysis
ea0011p101
Hypercalcaemia and hypereosinophilic syndrome in a patient with cholangiocarcinoma
ea0011p102
Di-George syndrome presenting with hypocalcaemia and personality disorder in adulthood a case report
ea0011p103
Phaeochromocytoma presenting as gestational diabetes
ea0011p104
Conns syndrome associated with hyperprolactinaemia: two case reports. Hypertension was cured by surgery in both cases despite a 10 and 16 year history
ea0011p105
Parathyroid carcinoma in multiple endocrine neoplasia (MEN) type 1: two case reports
ea0011p106
Co-existing hypoparathyroidism and vitamin D deficiency causing life-threatening hypocalcaemia
ea0011p107
A rare case of metastatic choroidal melanoma to the thyroid gland: the importance of cytology
ea0011p108
A complex case of pregnancy and pegvisamont treated acromegaly
ea0011p109
Post-partum thyroiditis (PPT): colour-doppler ultrasonography evaluation
ea0011p110
Challenges of managing metabolic disturbances
ea0011p111
Three generations of generalised resistance to thyroid hormone (GRTH)
ea0011p112
Mineral-rich baths an unusual source of exposure to excess iodine
ea0011p113
Biochemical screening for ret negative medullary thyroid carcinoma (MTC): a case report highlighting difficulties in the interpretation of pentagastrin stimulated calcitonin testing
ea0011p114
A long-standing lump in the neck proving troublesome for the surgeons
ea0011p115
A case of isolated acth deficiency who developed autoimmune-mediated hypothyroidism and hepatitis
ea0011p116
Cushings disease presenting as a Schizophreniform psychosis
ea0011p117
Obesity, hypertension and elevated catecholamines
ea0011p118
Cushings syndrome in an adolescent with MEN1: where is the lesion?
ea0011p119
Glucagonoma: does the clinical expression depend on the presence of inherited disease?
ea0011p120
A rare cause of gynaecomastia
ea0011p121
Is the continuation of lithium treatment safe during peri-operative periods?
ea0011p122
An unusual cause of jaundice
ea0011p123
Severe thyrotoxicosis and pregnancy
ea0011p124
Identification of two novel
GALNT3
mutations in a patient with familial tumoral calcinosis (FTC)
ea0011p125
Megadenoma
ea0011p126
Autoimmune hypophysitis causing permanent diabetes insipidus a case report
ea0011p127
Time course of neuroendocrine dysfunction after aneurysmal subarachnoid hemorrhage need for reassessment even years after the hemorrhage?
ea0011p128
A case of late onset congenital adrenal hyperplasia in a female epileptic patient: implications for clinical practice
ea0011p129
Adult-onset nesidioblastosis- a rare clinical case
ea0011p130
Seeking an appropriate sex of rearing in 5 α-reductase deficiency
ea0011p131
49,XXXXY syndrome connected with hypothyroidism
ea0011p132
Giant labia majora in familial partial lipodystrophy
ea0011p133
Pituitary apoplexy and acromegaly: a case report
ea0011p134
The effects of lanreotide administration vs unilateral adrenalectomy on disease activity in gip-dependent cushings syndrome
ea0011p135
Epilepsy at presentation of macroprolactinoma
ea0011p136
Difficulty to distinguish hyperandrogenia due to a tumoral formation or to polycystic ovary syndrome: a case report
ea0011p137
Resolution of diagnostic uncertainties with DAX-1 gene mutation analysis
ea0011p138
Multihormonal disorders in 17 year old girl with congenital hypoplastic anemia and secondary hemochromatosis
ea0011p139
Carcinoid tumour: spontaneous regression following pregnancy
ea0011p140
A rare cause of thyrotoxicosis and hypercalcemia
ea0011p141
Maternal virilization and female fetal pseudohermaphroditism caused by exaggerating androgen secretion of pregnancy leutomas
ea0011p142
Two unusual cases of extraadrenal phaeochromocytoma
ea0011p143
Prolonged hungry bone syndrome in a patient with wolfram syndrome: a case report
ea0011p144
Postmenopausal androgen excess: a clinical perspective
ea0011p145
Using of pulse methylprednisolon therapy in Graves ophthalmopathy
ea0011p146
Psycho-biological correlates of free-floating anxiety symptoms in male patients with sexual dysfunctions
ea0011p147
Challenges in the management of an uncommon cause of diabetes insipidus
ea0011p148
Psychiatric and movement disorders in primary hypoparathyroidism
ea0011p149
A case report of malignant insulinoma
ea0011p150
Malignant paraganglioma in young patient without symptoms a case report
ea0011p151
Secondary amenorrhoea induced by dihydrocodeine ingestion resolves following opiate withdrawal
ea0011p152
Combined cortisol and aldosterone hypersecretion in two unusual cases of hypertension due to adrenocortical neoplasia
ea0011p153
Endocrine disorders in a high secure hospital
ea0011p154
Acromegaly with a double pituitary adenoma
ea0011p155
17beta-hydroxysteroid dehydrogenase deficiency caused by homozygous h271r mutation
ea0011p156
Small intragenic somatic mutation associated with a germline mutation of HRPT2 gene in a patient with sporadic primary hyperparathyroidism
ea0011p157
Plasma exchange for the prevention of severe thyrotoxic exacerbation following radioactive iodine therapy for Graves hyperthyroidism
ea0011p158
Not-so-silent, silent corticotroph adenomas
ea0011p159
Cushings syndrome presenting with palpitations
ea0011p160
An unusual case of PTHrPoma with coexistent secondary hyperparathyroidism
ea0011p161
False positive newborn screen for congenital hypothyroidism due to a TSH-IgG (macro-TSH) complex
ea0011p162
Familial Hypocalciuric Hypercalcemia (FHH) caused by P748L mutation in the calcium sensing receptor (CaSR) gene
ea0011p163
Importance of complex evaluation of the changes in ST-segment in ECG: case report of the patient with Addison disease and Brugada syndrome
ea0011p164
Metformin-associated lactic acidosis in a caucasian woman precipitated by acute renal failure treated with bicarbonate haemodialysis
ea0011p165
Dysgerminoma and gonadoblastoma in children with complete androgen insensibility
ea0011p166
Chronic autoimmune thyroid disease in children and adolescents in Lower Silesia in the years 19992004
ea0011p167
Three extreme cases of electrolyte imbalance-induced seizures
ea0011p168
Two cases of idiopathic primary hypoparathyroidism
ea0011p169
Cushings syndrome due to medullary thyroid carcinoma a case report
ea0011p170
Polymyalgia rheumatica and Hashimoto thyroiditis
ea0011p171
Addisons disease: Soy Sauce a lifesaving concoction
ea0011p172
Pretibial Myxoedema: Is this a marker for occult thyroid ophthalmopathy?
ea0011p173
An unusual carcinoid tumor in a case of Cushing syndrome
ea0011p174
Clinical practise and governance
Audit on management of chronic adrenal insufficiency
ea0011p175
Salivary cortisol daycurve and Quality of Life assessment in optimizing glucocorticoid replacement therapy in patients with Addisons disease
ea0011p176
Symptom-specific thresholds for testosterone deficiency modulate complaints and metabolic risk in 434 aging male patients
ea0011p177
Longterm experience of more than 8 years with a novel formulation of testosterone undecanoate (Nebido) in substitution therapy of hypogonadal men
ea0011p178
Improvements for patients and nurses using 2.5 ml prefilled syringes as the vehicle solution for suspension of Sandostatin LAR
®
microspheres
ea0011p179
Impaired thirst and AVP release due to a reset osmostat in a patient with partial cranial diabetes insipidus (CDI) and subtle pituitary disease
ea0011p180
Reactive hypoglycaemia can measuring insulin concentrations help understand the pathophysiology and support diagnosis?
ea0011p181
Impaired quality of life in patients with adrenal insufficiency evidence that improved glucocorticoid replacement strategies are needed
ea0011p182
Long-acting, intramuscular TestosteronE undecanoatE (TU, Nebido
®
) in the treatment of female-to-male transgender individuals
ea0011p183
Long-acting intramuscular testosterone undecanoate (TU, Nebido
®
) in treatment of hypogonadal aging males
ea0011p184
Screening in primary care using fasting glucose uncovers significant hypoglycaemia including an asymptomatic insulinoma
ea0011p185
Comparison of the effect of sibutramine monotherapy with sibutramine-metformin combination therapy in nondiabetic obese women
ea0011p186
Torbay adrenal and pituitary project
ea0011p187
Autoimmune hypoadrenalism: the profile of related conditions
ea0011p188
Recombinant hGH therapy in males with organic GHD: should we trust in total testosterone levels for diagnosis of central hypogonadism?
ea0011p189
Survey of steroid replacement therapy
ea0011p190
Concordance between GH determination and IGF-I in acromegaly using two IGF-I methods
ea0011p191
Adult turner syndrome clinic: what are the patients perceptions of this specialist service?
ea0011p192
Adequacy of post-glucose gh nadir <1 μg/l to define biochemical and neuroradiological remission of acromegaly
ea0011p193
Patients with serum prolactin >20,000 mU/l review of presentation, management and outcome
ea0011p194
Long-term outcome in men with microprolactinoma
ea0011p195
Ophthalmic findings in turner syndrome
ea0011p196
Early detection of diabetic autonomic neuropathy with a new device
ea0011p197
Adult growth hormone replacement therapy after the institution of NICE guidelines
ea0011p198
Clinical evaluation of sheehan syndrome
ea0011p199
Is a repeat or resting prolactin necessary in the investigation of hyperprolactinaemia?
ea0011p200
Knowledge of testosterone replacement therapy is significantly correlated with patient satisfaction suggesting greater need for education
ea0011p201
Cushings disease an audit of outcomes following pituitary surgery from a single centre
ea0011p202
Clinical characterization of patients with hyperprolactinaemia due to macroprolactin
ea0011p203
Total cortisol and calculated free cortisol during the 250 μg ACTH test
ea0011p204
Comparison of the effects of transdermal and oral oestrogen treatments on serum and salivary cortisol concentrations
ea0011p205
A survey of gender dysphoria (transsexual) patients attending an endocrine clinic
ea0011p206
Osteoporosis, osteopaenia and osteoarthritis in autoimmune hypoadrenalism
ea0011p207
Autoimmune hypoadrenalism: symptoms at diagnosis
ea0011p208
Does HT still have a place? The impact on menopausal-related symptoms
ea0011p209
High mortality rate in hospital inpatients with hyponatraemia
ea0011p210
Comparative endocrinology
The patients with HIV lipodystrophy syndrome have lower total fat mass but similar free fat mass
ea0011p211
Dynamic macroprolactin and adjusted prolactin responses in hyperprolactinaemic patients
ea0011p212
Retrospective study of usefulness of Sestamibi scan in primary hyperparathyroidism
ea0011p213
Assessment of oxidative stress in patients with polycystic ovarian syndrome treated with either Orlistat or Metformin
ea0011p214
Prognostication in canine parvoviral diarrhoea using basal serum cortisol concentrations
ea0011p215
Short-term effects of propionate on the leptin system and on G protein-coupled receptor GPR41 mRNA levels in adipose tissue of goats
ea0011p216
Ontogeny of galanin and vasotocin immunoreactivity in the supraoptic nucleus (SON) and the bed nucleus of the stria terminalis (BSTM) in chickens
ea0011p217
Cytokines and growth factors
The role of IL-4 and IFN-gamma as prognostic factors of major adverse cardiac events in patients with ST-elevation myocardial infarction assigned primary percutaneous coronary intervention
ea0011p218
Adiponectin and resistin concentrations during oral glucose tolerance test (OGTT) in insulin-resistant subjects
ea0011p219
Effects of IGF-2 on glucose metabolism
ea0011p220
Interleukin 6 and transforming growth factor beta1 concentration in serum in patients with coronary vessels restenosis
ea0011p221
Immunosuppressive effect of recombinant human erythropoietin
ea0011p222
Low dose dexamethasone does not alter serum adiponectin or resistin concentrations
ea0011p223
Interleukin-6 and TNF-alpha in hemodilaysis patients: association with obesity and metabolic syndrome
ea0011p224
Vegf and sVCAM in patients with adrenal gland tumors
ea0011p225
Prolactin deficiency is independently associated with reduced IGF-I status in severely GHD adults
ea0011p226
GH/IGF-I axis and haematological alterations in anorexia nervosa
ea0011p227
Selected hormones serum levels in dependence on BMI and sex
ea0011p228
Abnormalities of humoral immunity with reduced immunogenicity to pneumococcal vaccine in panhypopituitarism
ea0011p229
Lack of influence of an IGF-I gene polymorphism on circulating IGF-I levels in severely GHD adults
ea0011p230
Serum TGF-β-1 levels in non-alcoholic steatohepatitis
ea0011p231
Subclinical hypothyroidism could be regarded as benign condition in oxidative stress but not in atherosclerosis
ea0011p232
Low TGF beta-1 serum levels in idiopathic male osteoporosis
ea0011p233
Possible predictive value of IGF-II mRNA expression in breast cancer (BC)
ea0011p234
IGF II protein expression in breast cancer. Relationship with the most important predictive parameters in breast malignancy
ea0011p235
The effect of growth hormone replacement on the diurnal and ultradian dynamics of ghrelin and leptin in adult growth hormone deficiency
ea0011p236
Growth hormone receptor extracellular domain linked to glycophosphatidyl inositol (GHR-GPI); a potential growth hormone receptor antagonist
ea0011p237
The depot specific expression of NPY in human adipose tissue and its upregulation under hyperinsulinaemic conditions in isolated human adipocytes
ea0011p238
The role of BMPs in the establishment of zona glomerulosa in the adrenal gland
ea0011p239
Anosmin-1: a novel cofactor for fibroblast growth factor receptor 1
ea0011p240
Effect of growth hormone deficiency in adults on insulin action and gene expression of selected adipokines in subcutaneous adipose tissue
ea0011p241
Soluble interleukin 2 receptor is elevated in sera of women with Graves disease and has relation to serum free thyroxin and thyroid volume
ea0011p242
Molecular mechanisms of idiopathic muscle hypertrophy in humans
ea0011p243
CD4 T-cell count improves during sustained IGF-I response following low dose growth hormone therapy in HIV-infected patients on stable antiretroviral regimens. A pilot study
ea0011p244
The differential influence of specific plant lectins on insulin and IGFs binding to solubilised placental membrane IGF and insulin receptors
ea0011p245
GH and GH antagonist B2036 effect on the immune system
ea0011p246
IGF-I modulates HIF-1α and HIF-2 α in Kaposi Sarcoma
ea0011p247
Proinflammatory cytokine gene expression shows intrinsic circadian oscillation in peripheral cells
ea0011p248
Plasma interleukin 18 in patients with polycystic ovary syndrome relation to insulin resistance
ea0011p249
Expression of functional toll-like receptors in adipocytes
ea0011p250
Diabetes, metabolism and cardiovascular
The involvement of GH-IGF-I axis in a mouse model of type II diabetic nephropathy
ea0011p251
Sodium bicarbonate reacts with polysaccharides starch to enhance exercise
ea0011p252
New function for the enzyme amylase discovered: amylase works as a catalyst/hydrolyzing agent to break down, disaccharides (sucrose, lactose, maltose… etc) and polysaccharides (starch)
ea0011p253
Liver GH receptor signaling in type I diabetic mice
ea0011p254
The effects of changes in insulin sensitivity on androgen supply values in diabetic men at different age
ea0011p255
The effect, in clinical practice, of long-acting fluvastatin (LAF) on low density lipoprotein-cholesterol (LDL-Ch) in patients with type 2 diabetes mellitus (T2DM) in which other statins have failed to achieve the goals
ea0011p256
Nutritional outcome in end-stage renal disease diabetic patients: short term follow-up of patients initiating/escaping dialysis
ea0011p257
Improvement of nutritional status in non-dialysed uremic diabetic patients
ea0011p258
Subthalamic nucleus stimulation in parkinsonian patients does not increase serum ghrelin levels
ea0011p259
Hyperandrogenism as a risk factor of coronary artery disease in young women
ea0011p260
Comparison of urinary N-Acytyl β-D glucoseaminidase activity in diabetic patients and controls
ea0011p261
Association of hypogonadism and type 2 diabetes in men attending an outpatient erectile dysfunction clinic
ea0011p262
Estimation of the lipid metabolism in women with gestational diabetes mellitus (part 2). Differences resulting from the method of treatment
ea0011p263
Estimation of some parameters of lipid metabolism in pregnant women with gestational diabetes mellitus
ea0011p264
The role of a lifestyle modification in preventing type II diabetes mellitus in subjects with high-risk factors
ea0011p265
The effect of Greek mediterranean diet on trace elements and blood coagulation factors in type 2 diabetic patients
ea0011p266
12 month audit of insulin glargine use in the diabetic clinic
ea0011p267
Increased expression of the adipokines resistin and fiaf in hypoxic/ischemic mouse brain
ea0011p268
Prevalence of chronic cardiovascular complications in newly diagnosed type 2 diabetic patients
ea0011p269
Hormonal profile associated with the insulin sensitive obese subjects
ea0011p270
AT
1
receptor activation mediated oxidative stress and uncoupling protein-2 driven beta-cell dysfunction in obesity-induced Type 2 diabetes mellitus
ea0011p271
Effects of hyperglycemia on the AT
1
receptor expression and secretory function in an INS-1E beta-cell line
ea0011p272
Evaluation of Garlic extract effect on serum angiotensin converting enzyme (ACE) level in streptozotocin-diabetic rats
ea0011p273
Determinants of metabolic syndrome and insulin resistance in hemodialysis patients
ea0011p274
Hyperlactatidemia caused by acute myocardial infarction in patients with type 2 diabetes mellitus
ea0011p275
The safety and efficacy of chinese herbal medicine PHS-e2 (Glucoherb) in streptozotocin induced diabetic wistar rats
ea0011p276
Education for diabetic patients for fasting of Ramadan: a questionnaire study
ea0011p277
Alcohol intake deteriorates insulin receptors and adipokines expression in rat adipose tissue
ea0011p278
Des-acyl ghrelin regulates glucose and lipid metabolism in HL-1 cardiomyocytes
ea0011p279
Regulation of brain-derived resistin and FIAF in a novel hypothalamic neuronal cell line
ea0011p280
Myocardial ischemia in type 1 diabetic patients re-examination after four years
ea0011p281
The metabolic syndroma presence in peripheral arterial occlusive disease of diabetic patients
ea0011p282
A TCF1 mutation may cause transient congenital hyperinsulinism followed by MODY3
ea0011p283
Waist circumference cut-offs for categorisation among Tunisian adult population
ea0011p284
Associations between bmi and smoking with reference to other life style factors, the 4th and the 5th Tromsø studies
ea0011p285
Gene variants at calpain-5 locus are associated with obesity and other features of metabolic syndrome
ea0011p286
Plasma concentrations of asymmetric dimethyl arginine and total homocysteine in siblings of type 2 diabetes mellitus
ea0011p287
Mortality risks of diabetic patients who reach end stage renal disease (ESRD) in the united states: age and gender differences
ea0011p288
Hormonal profile in men suffering from coronary artery disease and metabolic syndrome
ea0011p289
The impact of vitamins and/or minerals supplementation on blood pressure in type 2 diabetes
ea0011p290
Pro12Ala PPAR gamma2 gene polymorphism in PCOS women - the role of the satiety and insulin activity regulating compounds
ea0011p291
Glucose metabolism, insulin secretion and insulin sensitivity in juvenile hemochromatosis
ea0011p292
Glucocorticoids are metabolised within perivascular adipose: the link between metabolic diseases and their vascular consequences?
ea0011p293
Absence of sexual dimorphism in the symptomatic responses to hypoglycaemia in adults with and without type 1 diabetes
ea0011p294
Metabolic syndrome and insulin sensitivity in early glycoregulation disorders
ea0011p295
Biochemical predictors of the cardiovascular complications in patients with obesity and type 2 diabetes
ea0011p296
Decreased cardiac and arterial noradrenaline and dopamine concentrations occur concomitantly with the development of type II diabetes in rats treated neonatally with monosodium glutamate (MSG): a possible basis for autonomic neuropathy?
ea0011p297
Gender distribution in Ukrainian adult insulin-treated diabetics depending of age at diagnosis
ea0011p298
Effects of arm exercise on metabolic parameters in type 2 diabetic patients
ea0011p299
The ethanolic extract of
Combretum decandrum
Roxb. improved glucose tolerance and increased glucose uptake of hyperinsulinemic rats
ea0011p300
In-patients food intake and reasons of non-consumption
ea0011p301
Renal expression of alpha-ENaC is increased in testosterone treated rats
ea0011p302
Insulin resistance syndrome (IRS) and non-alcoholic fatty liver disease (NAFLD) in obese children: influence of ethnic background, sex, age and family history of type 2 diabetes (T2DM)
ea0011p303
Serum ghrelin levels during oral glucose challenge new insights from gastrectomized patients
ea0011p304
A gene gene interaction of single nucleotide polymorphisms within two oxidative stress genes affects arterial compliance in patients with coronary artery disease
ea0011p305
The variable number of tandem repeat polymorphism in the NOS3 gene is associated with arterial compliance and insulin resistance in coronary artery disease
ea0011p306
Altered cholesterol and bile acid homeostasis in the hexose-6-phosphate dehydrogenase (H6PDH) knockout mouse
ea0011p307
Insulin secretion in HBV and HCV infected patients with type 2 diabetes mellitus
ea0011p308
The pancreatic beta-cells autoantibodies in HBV and HCV infested patients with type 2 diabetes mellitus
ea0011p309
Adrenomedullin increases the expression of CLR and RAMP2 in microvascular endothelial cells
ea0011p310
Sympathetic function in carriers of MC4R mutations
ea0011p311
A case of myocardial infarction induced by factitious hypoglycaemia in type 2 diabetes patient
ea0011p312
Orlistat improves postprandial triglyceride metabolism in obese patients with or without diabetes
ea0011p313
Challenge in Achieving Target Hba1c in a relatively rare Diabetes complication
ea0011p314
Depot specific activation of inflammatory signalling molecules JNK and NFκB in human abdominal subcutaneous and omental adipose tissue
ea0011p315
Endothelial, inflammatory and endocrine markers in women with PCOS before and after metformin treatment
ea0011p316
Expression and regulation of adiponectin receptors (AdR-1 and AdR-2) in pancreatic beta-cells
ea0011p317
Cardiovascular risk factors and macrovascular complications in type 2 diabetes
ea0011p318
Effects of Ezetimibe on serum lipoproteins in patients with homozygous familial hypercholesterolemia undergoing LDL cholesterol apheresis and high dose atorvastatin therapy
ea0011p319
Effect of micronised fenofibrate on plasma levels of c-reactive protein in combined hyperlipidemia
ea0011p320
Long term safety of Atorvastatin and Fenofibrate therapy in patients with combined hyperlipidemia
ea0011p321
Use of insulin glargine during pregnancy in women with type 1 diabetes mellitus
ea0011p322
Serum ferritin levels and obesity
ea0011p323
Utility of continuous glucose monitoring (CGMS) to explore glycemic patterns in patients with diabetes mellitus in the UAE
ea0011p324
Dyslipidemia in premenopausal and postmenopausal obese women
ea0011p325
The effect of moxonodine on endothelial dysfunction in metabolic syndrome
ea0011p326
The BsmI and FokI polymorphisms in the vitamin D receptor gene in relation to anthropometric and biochemical parameters describing metabolic syndrome
ea0011p327
Comparison between NPH insulin and insulin glargine in intensive insulin therapy in type 1 diabetes mellitus
ea0011p328
Association of c-reactive protein with insulin resistance in first degree relatives of diabetic patients
ea0011p329
How does glucose insulin potassium improve haemodynamic performance? Evidence for beta-adrenoreceptor and sarcoplasmic reticulum calcium ATPase up-regulation
ea0011p330
Effects of weight loss on the coronary risk profile in obese patients two years after bariatric surgery
ea0011p331
The severity of cardiovascular disease in women is modified by estrogen receptor alpha polymorphic variants
ea0011p332
Adult pancreatic islet progenitor cells exhibit plasticity
in vitro
ea0011p333
Regulation of hexose-6-phosphate dehydrogenase (H6PDH) in human fetal liver WRL-68 cells
ea0011p334
Relationships between plasma adiponectin and testosterone concentrations in middle-aged men and women
ea0011p335
Relationship between testosterone and
in vivo
expression of adipoR1 in skeletal muscle in middle aged Caucasian men
ea0011p336
Testosterone secretion and melatonin rhythm in men with the metabolic syndrome
ea0011p337
Mortality and morbidity are objective epidemiological indices that reflect state of diabetic aid in region
ea0011p338
Prevalence of diabetic foot syndrome among diabetes patients
ea0011p339
Decreased cutaneous vasomotor responses in patients with insulin resistance
ea0011p340
Lipid profile in normal weight and obese women with polycystic ovary syndrome
ea0011p341
Is ghrelin a potential signal of decreased fat-free mass in elderly subjects?
ea0011p342
Obesity and expression of serotonin transporter (SERT) in human platelets
ea0011p343
Acute and chronic effect of teriparatide on glucose metabolism in women with established osteoporosis
ea0011p344
Adipose glucocorticoid synthesis: transcription of the 11β-hydroxylase gene in omental but not subcutaneous adipose tissue
ea0011p345
Metabolic syndrome among patients with primary aldosteronism: a common feature?
ea0011p346
Metabolic parameters in patients with primary aldosteronism: relation to snps of the adiponectin gene
ea0011p347
Coronary artery disease and heart failure in diabetic patients in the north of portugal
ea0011p348
Physiological concentrations of testosterone inhibit extracellular calcium entry
via
voltage-gated calcium channels in the A7r5 vascular smooth muscle cell line - a non-genomic effect
ea0011p349
Comparison between premixed insulin aspart 30
vs
premixed human insulin 30/70 in combination with metformin in obese type 2 diabetic patients
ea0011p350
Effect of repaglinide vs glimepirid on glycaemic control in overweight and obese patients with type 2 diabetes mellitus uncontrolled by metformin
ea0011p351
Association of an insertion/deletion polymorphism in the alpha 2B adrenergic receptor with essential hypertension in diabetic patients
ea0011p352
The metabolic syndrome and insulin resistance in polycystic ovary syndrome study over 40 patients
ea0011p353
Prevalence of registered diabetic nephropathy and its terminal stages
ea0011p354
Noninsulinoma pancreatogenous hypoglycaemia syndrome (NIPHS) caused by an activating glucokinase mutation
ea0011p356
Relationship between plasma visfatin levels and the metabolic variables in metabolic syndrome
ea0011p357
The vasodilatory action of oestrogen in isolated human pulmonary arteries
ea0011p358
The effect of fluvastatin on adiponectin and insulin sensitivity
ea0011p359
Leptin as a regulator of serum acylated ghrelin in normal-weight and obese premenopausal women
ea0011p360
Insulin receptoropathies are distinguished from other syndromes of severe insulin resistance by elevated plasma adiponectin levels
ea0011p361
Impaired endothelial function in young non-obese women with polycystic ovary syndrome: Normalization with Ethinyl Estradiol-Cyproterone Acetate treatment
ea0011p362
Carbohydrate metabolism in children with Down syndrome
ea0011p363
Anti-oxidative effect of 17beta-estradiol in human endothelial cells: the role of Bcl-2
ea0011p364
Emergence of new addictions following gastric reduction surgery for morbid obesity
ea0011p365
Is there male androgenetic alopecia the sign of male equivalent of polycystic ovary syndrome or metabolic syndrome?
ea0011p366
Increased prevalence of the metabolic syndrome by NCEP, WHO and IDF criteria in women with PCOS
ea0011p367
Estrogen receptor alpha (ER alpha) gene polymorphisms and first-ever primary intracerebral hemorrhage (PICH)
ea0011p368
The metabolic control levels of 548 diabetic outpatients compared with the current guidelines of Polish Diabetes Association (PDA)
ea0011p369
Increased sub-clinical inflammation and markers of vascular injury in obese children
ea0011p370
Clinical, functional and polysomnographics parameters in severely obese patients
ea0011p371
The role of tumour necrosis factor-alpha in insulin-stimulated endothelial nitric oxide production
ea0011p372
Correlation of WBC and PLT count with parameters of type 2 diabetes mellitus
ea0011p373
Field evaluation of a multi-sensor armband in Greek women
ea0011p374
The acute stimulation of nitric oxide synthesis by rosiglitazone in human aortic endothelial cells is independent of the PPAR gamma receptor but is dependant on the fuel sensing enzyme AMPK
ea0011p375
Dehydroepiandrosterone in relation to obesity, insulin resistance and lipid spectra in Czech non-diabetic population
ea0011p376
Frequency of dyslipidemiαs in children results of lifestyle intervention
ea0011p377
SiRNA-mediated depletion of synaptotagmin-11 abrogates insulin-stimulated glucose uptake in 3T3-L1 adipocytes
ea0011p378
Chromosome 1p shows significant linkage to steroid metabolism in hypertension in the British Genetics of Hypertension Study
ea0011p379
Impaired glucose metabolism in patients with Cushings Syndrome
ea0011p380
Effects of bariatric surgery on preclinical myocardial alterations in severe obesity and the related role of insulin resistance
ea0011p381
The effect of an 18 week group exercise education program on weight, physical activity, cardiovascular fitness, quality of life and attitudes to exercise in obese irish female adults
ea0011p382
Direct effect of cannabinoids and ghrelin on liver and adipose cell metabolism via the AMP-activated protein kinase (AMPK) enzyme
ea0011p383
Expression and Localisation of human tissue kallikrein in transfected human embryonic kidney cells (HEK-293). Development of a novel panel of monoclonal antibodies (mAbs) against human tissue kallikrein
ea0011p384
Dietary regulation of peripheral glucocorticoid action: comparison of saturated and unsaturated fats
ea0011p385
The KCNJ11 E23K and UCP2 G-866A SNPs in relation to DM2 in Czech population
ea0011p386
Androgen regulation of hepatic glucocorticoid metabolism in obese Zucker rats
ea0011p387
Plasma N-terminal pro-brain natriuretic peptide and adiponectin levels increases during weight loss
ea0011p388
Multiple signalling pathways are involved in the phosphorylation of ERK1/2 upon activation of human OX1R and OX2R: Evidence for differential modulation by orexin-A and orexin-B
ea0011p389
Association among individual deprivation using the EPICES score and anthropometric factors linked to abdominal and metabolic markers
ea0011p390
Mapping of adiponectin and adiponectin receptors in the human adult and fetal heart
ea0011p391
Testosterone replacement therapy reduces insulin resistance, and improves glycaemic control in hypogonadal men with Type 2 diabetes
ea0011p392
Functional analysis of cardiac orexin receptors: preferential activation by OR-B
ea0011p393
Orexin receptor expression in human adipose tissue: differential effects of orexins
ea0011p394
Insulin sensitivity and lipid profile in obese and normal weight hypertensive subjects
ea0011p395
Human adipocytes attenuate cardiomyocyte contraction. A direct link between heart failure and obesity
ea0011p396
Dietary potassium driven responses in the renal WNK kinase pathway
in vivo
ea0011p397
The
in vitro
and
in vivo
role of diabetic status and insulin sensitisers on the novel adipocytokine, visfatin
ea0011p398
Adrenocortical function in obese Zucker rats
ea0011p399
Recurrence rate of atrial fibrillation in amiodarone-induced hyperthyroidism
ea0011p400
The effect of hyperthyroidia on glycemic control in patients with diabetes mellitus
ea0011p401
Flow mediated dilatation and svcam concentration as the markers of endothelial dysfunction in patients with acromegaly
ea0011p402
Low endogenous testosterone induces fatty streak formation following cholesterol feeding in the testosterone deficient testicular feminised mouse and castrated male
ea0011p403
Testosterone replacement reduces aortic fatty streak formation in testosterone deficient Tfm mice following feeding on a cholesterol-enriched diet
ea0011p404
Growth hormone and IGFBP-3 but not IGF-1 are independent predictors for insulin sensitivity in healthy subjects: on the role of hGH in the metabolic syndrome
ea0011p405
Dehydroepiandrosterone inhibits differentiation, proliferation and 11β-hydroxysteroid dehydrogenase type 1 activity in human preadipocytes
ea0011p406
Urocortin 2 mediates glucose utilization and insulin sensitivity in skeletal muscle
ea0011p407
Elevated serum hs-CRP in the obese still much to be explained
ea0011p408
Lipoprotein Lp(a) in patients with systemic lupus erythematosus
ea0011p409
Effects of alcoholic extract of walnut (
Juglans regia
L.) septum on serum lipids and Activities of serum aminotransaminase enzymes in streptozocin-induced diabetic rats
ea0011p410
The ways in which zinc enters beta cells in the pancreas and the influence of zinc blockers on the development of type 1 diabetes
ea0011p411
Lipoprotein Lp(a) in patients with rheumatoid arthritis
ea0011p412
Polymorphisms in insulin-like growth factor binding protein-1 (IGFBP-1) are associated with altered circulating IGF-I and lower body mass index in type-2 diabetes mellitus
ea0011p413
Polymorphisms in insulin-like growth factor binding protein-1 (IGFBP-1) are associated with increased type-2 diabetes mellitus prevalence
ea0011p414
Cardiac autonomic neuropathy in relation to some components of metabolic syndrome in newly diagnosed type 2 diabetic patients
ea0011p415
Severity of depression in patients with type 1 and type 2 diabetes and its relation to the level of glycemia control and anti-depressive therapy
ea0011p416
Cardiac autonomic and peripheral neuropathy in newly diagnosed type 2 diabetic patients
ea0011p417
Rapid effect of repaglinide in combination with metformin in poorly controlled obese patients with type 2 diabetes mellitus
ea0011p418
Impact of migration on circulating adipocytokines in an Asian Indian population
ea0011p419
Migration to the UK results in significantly lower testosterone levels in South Asian men
ea0011p420
Prevalence of skin manifestations in diabetics
ea0011p421
Correlations between leptin, insulin resistance and lipid profile in postmenopausal women
ea0011p422
Correlation between glycemia levels and mortality rate in patients with type 2 diabetes and prior myocardial infarction
ea0011p423
Left ventricular geometry and contractile ability in type 2 diabetes and non-diabetic patients with mild hypertension
ea0011p424
Effect of lacidipine on left ventricular mass and blood pressure circadian rhythm in hypertensive diabetic patients
ea0011p425
Endocrine disruptors
Prevalence of the phyto-oestrogen urinary metabolites enterodiol and enterolactone in patients under endocrine investigation
ea0011p426
Comparative review of primary and secondary empty sella syndrome
ea0011p427
Adults primary empty sella
ea0011p428
The UV filter benzophenone 2 inactivates human recombinant thyroperoxidase
in vitro
and disturbs thyroid hormone homeostasis in rats
ea0011p429
Endocrine disorders in thallasaemia local experience in an inner city hospital in Birmingham, England
ea0011p430
Extracts of black cohosh (
Actaea racemosa
) inhibit growth of MCF-7 and MDA-MB-231 breast cancer cells and dose-dependently inhibit oestrone sulphatase activity
ea0011p431
Androgen-dependent Sertoli cell proliferation as a target for endocrine disruptors relevant to human male reproductive health
ea0011p432
A randomized, open-label, multicenter study to evaluate octreotide LAR with surgical therapy as primary therapy patients with acromegaly
ea0011p433
Origin of dysgenetic areas in testes of rats exposed to Di
n
-butyl phthalate (DBP) during fetal life: A model of human testicular dysgenesis syndrome
ea0011p434
Endocrine disruptors and idiopathic gynecomastia with aromatase gene polymorphism
ea0011p435
Loss and resumtion of ovarian function after mitotane administration
ea0011p436
Endocrine tumours and neoplasia
Estrogen receptor alpha and beta (ERα and -β) gene and protein expression in breast cancer cell lines: verification by RT-PCR and Western blotting
ea0011p437
Challenges associated with the diagnosis, differential diagnosis and treatment of 4 cases of ACTH-dependent Cushings syndrome due to intermittent hypercortisolism
ea0011p438
Hyperprolactinaemia in a series of adults with craniopharyngiomas and Rathkes cleft cysts: what are the upper limits?
ea0011p439
Parathyroid scinigraphy for hyperparathyroidism, an assessment of performance
ea0011p440
Insulinomas an experience from a tertiary care institution in South India
ea0011p441
Biological diagnosis of 63 pheochromocytomas and/or paragangliomas
ea0011p442
Dedifferentiated papillary thyroid cancer. Use of array CGH in searching for prognostic markers
ea0011p443
Stereotactic conformal radiotherapy in pituitary adenomas outcome in 36 consecutive patients during years 19962004
ea0011p444
Intra-ovarian adrenocortical carcinoma
ea0011p445
Comparative efficacy of therapy with sandostatin and parlodel in patients with acromegalia
ea0011p446
Pituitary tumors in republic of Croatia
ea0011p447
Histological peculiarities of pituitary adenomas
ea0011p448
Surgical treatment in acromegaly: predictors of outcome
ea0011p449
Pituitary mass and hypothyroidism. A case report
ea0011p450
Incidence rate of thyroid cancer in Olsztyn region in the years 19932004
ea0011p451
A typical clinical picture of four insulinoma cases
ea0011p452
What is the best glycaemic index for the diagnostic of insulinoma?
ea0011p453
Sustained correction of hypercortisolism with a low dose mitotane regimen in a young woman with PPNAD and Carney Complex
ea0011p454
Hypocorticism after radiosurgery (protonotherapy) in patients with normal MRI and in patients with confirmed tumor for Cushings disease
ea0011p455
Prognostic value of KI-67 expression in the cytologic identification of pancreatic endocrine tumors: preliminary data
ea0011p456
Difficulties in diagnosing persistent acromegaly using current consensus criteria for cure after transsphenoidal surgery
ea0011p457
Carbohydrate metabolism in patients with hypercorticism
ea0011p458
Role of family history for diabetes mellitus in determining insulin resistance in acromegalic patients
ea0011p459
Familial acromegaly
ea0011p460
Role of complex Cdk4/Cyclin D1 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line
in vitro
ea0011p461
Selective Cyclo-oxygenase 2 inhibitors revert chemoresistance In Medullary thyroid carcinoma by a mechanism mediated by P-gp and PGH
2
ea0011p462
An intrasellar germinoma with normal cerebrospinal fluid β-HCG concentration misdiagnosed as hypophysitis
ea0011p463
Response to medical treatment in male macroprolactinomas
ea0011p464
Non functioning pituitary tumors
ea0011p465
Diabetic retinopathy in acromegaly
ea0011p466
Malignant catecholamine-secreting paragangliomas of retrocardial localization
ea0011p467
Short-term evaluation of quality of life in acromegalic patients
ea0011p468
Octreotide as alternative to surgically adrenalectomy
ea0011p469
Inhibition of IGF-II signal transduction improves chemosensitivity in human adrenocortical cancer cells
ea0011p470
The new TNM classification is inferior to the Lee classification in predicting outcome in patients with adrenocortical carcinoma
ea0011p471
Stimulated and spontaneous growth hormone release in irradiated acromegalic patients
ea0011p472
WNT4 expression in normal human adrenals and adrenocortical tumours
ea0011p473
The clinical particularities, medical possibility of prolactonomas in men
ea0011p474
Management of thyroid cancer in children
ea0011p475
Diagnosis difficulties in insulinomas
ea0011p476
Insulin-like growth factor-i signalling in tamoxifen sensitive and tamoxifen resistant breast cancer cells
ea0011p477
Functioning adrenocortical carcinoma and the clinical endocrinologist: toxic treatments and poor prognosis
ea0011p478
Post-operative serum cortisol for prediction of long-term remission from Cushings syndrome
ea0011p479
An in-frame complex germline mutation in the juxtamembrane intracellular domain causing
RET
activation in familial medullary thyroid carcinoma
ea0011p480
Macroprolactinoma: 5 cases
ea0011p481
48 h appears as sufficient duration of fasting in the diagnosis of insulinoma a single centre experience with 23 cases
ea0011p482
A case of a patient with differentiated thyroid carcinoma and metastases to the kidneys
ea0011p483
Development of a non-isotopic immunoassay for the measurement of aldosterone in saliva
ea0011p484
Thyroid autoimmunity disorders and breast cancer (BC): absence of morphological autoimmune changes in breast malignant tissue
ea0011p485
Pituicytoma a case report
ea0011p486
PTTG promotes a novel VEGF-KDR-ID3 autocrine mitogenic pathway in thyroid cancer
ea0011p487
Multiple Endocrine Neoplasia Type 1 (MEN 1) is associated with insulin resistance and an increased prevalence of diabetes and impaired fasting glucose
ea0011p488
Evaluation of a standardized protocol for the collection and storage of adrenal tumor samples preparation for an European adrenal tumor bank (ENS@T)
ea0011p489
Value of overnight dexamethasone suppression test (1 mg-dst) in subclinical Cushings syndrome
ea0011p490
Effect of catecholamine uptake inhibition on catecholamine content in human adrenal chromaffin cells and pheochromocytes
ea0011p491
PTTG binding factor (PBF) can transform cells independently of interaction with PTTG
ea0011p492
Carneys complex with acromegaly as the leading clinical condition
ea0011p493
Daily profiles of aldosterone secretion in primary aldosteronism
ea0011p494
Analysis of succynyl dehydrogenase (SDH) subunits gene mutations in patients with paragangliomas
ea0011p495
Neuropeptide Y-Y1 receptors mediate the effects of neuropeptide Y on prostate cancer cell growth
ea0011p496
Differential expression of neurogenins by human pituitary adenomas
ea0011p497
Evidence for an attenuated 11 β-hydroxysteroid dehydrogenase type-1 (11βHSD1) response to an inflammatory stimulus in primary cultures of epithelial ovarian cancer
ea0011p498
Long-term somatostatin analog octreotide treatment in insulinoma patients
ea0011p499
Development of dopamine agonist resistance and progression from microadenoma to macroadenoma in two women with hyperprolactinaemia
ea0011p500
The rare RET mutation (insTTCTdelG) at codon 666 is associated with a low penetrance of medullary thyroid carcinoma and pheochromocytoma
ea0011p501
Use of TRH in addition to CRH stimulation during bilateral inferior petrosal sinus sampling in Cushings syndrome long term experience
ea0011p502
Glucagonoma syndrome treatment with intensive insulin and high dose vitamin B
ea0011p503
Headaches cured by surgery
ea0011p504
Chromogranin-A in adrenal incidentalomas marker for tumour secretion
ea0011p505
A novel germ-line mutation gly321arg in the exon 5 of the ret proto-oncogene detected in a family with familial medullary thyroid carcinoma
ea0011p506
Contemporary management of macroprolactinomas
ea0011p507
Cushings paraneoplastic syndrome secondary to recurrent ovarian carcinoma
ea0011p508
Moleculargenetic and clinical characterisation of neurofibromatosis type 1 associated pheochromocytoma
ea0011p509
AcroBel: a registry and survey on acromegaly in Belgium
ea0011p510
The latest safety and efficacy data of patients treated with Pegvisomant
ea0011p511
Mutation at codon 804 detected in a Greek kindred by screening of the RET gene in patients with medullary thyroid carcinoma
ea0011p512
A rare RET gene mutation is found in two apparently unrelated Greek kindreds with familial medullary thyroid carcinoma
ea0011p513
Surgical cure with preserved pituitary function is rare in acromegalic patients. Results from the Preoperative Octreotide Treatment of Acromegaly (POTA) study
ea0011p514
Different scintigraphic patterns between sympathetic and parasympathetic paragangliomas
ea0011p515
mRNA expression of somatostatin receptor subtypes in pheochromocytomas/paragangliomas
ea0011p516
A retrospective review of the effect of pituitary radiotherapy after transsphenoidal surgery for non-functioning pituitary adenomas
ea0011p517
Biochemical characteristics of silent ACTH-secreting pituitary adenomas: Preoperative serum and urine hormone studies
ea0011p518
Radiotherapy and o,p-DDD induce an inhibition of growth and interfere in the cell cycle in H295-R adrenocortical cell line
ea0011p519
Role of PKA regulatory subunit 2B protein on cortisol-secreting adrenocortical cells proliferation
ea0011p520
Outcome of management of craniopharyngiomas a contemporary series
ea0011p521
Anatomo-clinical features in multihormonal prolactinomas
ea0011p522
Glucocorticoid receptor gene N363S variant in patients with clinically inapparent adrenal adenomas
ea0011p523
Characteristics and follow up of thyroid cancer in patients with hyperthyroidism
ea0011p524
Investigation and surgical management of pancreatic neuroendocrine tumours
ea0011p525
Estrone and cortisol co-secreting adrenocortical carcinoma in a man presenting with hypogonadotrophic hypogonadism and painful gynaecomastia
ea0011p526
Origin and spread of the SDHD p.Y114C mutation causing head and neck paraganglioma in Trentino, Italy
ea0011p527
Characterization of familial non-syndromic pheochromocytoma
ea0011p528
Endostatin and VEGF levels in serum of patients with pituitary tumors
ea0011p529
18F-deoxy-D-glucose positron emission tomography (FDG_PET) increases the detection rate of recurrent or residual medullary thyroid cancer
ea0011p530
Papillary thyroid microcarcinoma: a low risk neoplasia?
ea0011p531
The value of fluorine-18 fluorodeoxyglucose PET during follow-up of patients with medullary thyroid carcinoma
ea0011p532
N363S and BclI variants in the glucocorticoid receptor gene and their associations in Cushings syndrome and Addisons disease
ea0011p533
Novel inactivating mutations in four Italian cases of familial hypocalciuric hypercalcemia
ea0011p534
Genetic analyses of familial isolated primary hyperparathyroidism: implications for clinical assessment and surgical management
ea0011p535
Non-pancreatic carcinoid tumours - prognostic value of proliferative index (Ki67%)
ea0011p536
Somatostatin receptor subtypes 15 in pituitary tumors of various etiologies: investigation by immunohistochemistry
ea0011p537
High performance liquid chromatography (HPLC) in the follow-up of mitotane therapy in a patient with adrenal carcinoma
ea0011p538
Multiple endocrine neoplasia type 1 and angiomyxoma
ea0011p539
Novel L30LR heterozygous mutation of the menin gene in a Hungarian MEN 1 family
ea0011p540
Differences in the presenting biochemical and imaging data in patients with acromegaly caused by pure GH adenomas, adenomas with GH and PRL cell differentiation and plurihormonal adenomas
ea0011p541
Management of thyrotrophin-secreting adenoma with octreotide therapy
ea0011p542
Tumor size and gonadotrophin immunoreactivity of pituitary adenomas
ea0011p543
Carotid arterial intima-media thickness (IMT), a marker of atherosclerosis, does not differ in patients with acromegaly compared to healthy controls
ea0011p544
Acute biliary tract problems are common on discontinuation of somatostatin analogue (SA) therapy
ea0011p545
Cell proliferation and outcome of GH-secreting pituitary adenomas
ea0011p546
Efficacy and safety of high doses of long-acting somatostatin analogues for treatment of well differentiated functioning neuroendocrine tumors
ea0011p547
Surgical debulking of GH secreting adenomas improves control of acromegaly by lanreotide a prospective study
ea0011p548
Diagnostic utility of dexamethazone suppression tests in the work-up of Cushings disease
ea0011p549
Descriptive epidemiology of thyroid cancer occurring in the population living in the Rhône Alpes region: 19982004
ea0011p550
In vitro
effects of som230 on primary cultured pheochromocytoma cells
ea0011p551
Fourier transform infrared spectroscopy (FTIR) of parathyroid pathology
ea0011p552
Growth and development
Prevalence of the main GH receptor polymorphisms in GH deficient children and in the general population
ea0011p553
Developmental control of tissue deiodinases by cortisol in fetal sheep during late gestation
ea0011p554
Significance of neonatal steroid imprinting and of peripubertal growth hormone excess for the development of prostatic hyperplasia in the rat
ea0011p555
Adrenal (interrenal) development in the zebrafish
ea0011p556
Comparison of dietary pattern and food habits in urban and rural adolescent girls in Gilan/IRAN
ea0011p557
Effective factors on status of nutritional education in primary school children, Tehran, Iran: A Focus Group Discussion (FGD)
ea0011p558
Morphological changes of pituitary region in primary GH deficiency
ea0011p559
Growth without growth hormone: normal final height of four patients with multiple pituitary hormone deficiency
ea0011p560
RAD21-dependent effects of securin/PTTG and separase on fetal neuronal NT2 cells
ea0011p561
Leukemia inhibitory factor promotes the chemomigration of immature GNRH neurons
ea0011p562
The study of nutrition with different salt concentrations in prenatal period on BP, tissue changes NA and aldosterone level in next generation
ea0011p563
Sodium, Birth weight, adult weight and Bp in adulthood
ea0011p564
Embryonic gene expression affected by different sodium concentrations
ea0011p565
Sodium changes autonomic nervous response
ea0011p566
Lipid peroxidation, activity of caspase 3 and apoptosis activation in low birth weight children
ea0011p567
Growth hormone induced improvement in quality of life does not correlate with reduction in vascular risk in adult hypopituitary patients
ea0011p568
The response of infants adrenal gland and salt appetite, aldosterone and Na serum level to mothers salt consumption
ea0011p569
Maternal testosterone levels during pregnancy are associated with offspring size at birth
ea0011p570
Mortality in growth hormone deficiency
ea0011p571
The cardiovascular risk profile and carotid IMT of adults with partial GH deficiency
ea0011p572
Double blind placebo controlled study on the impact of RGH replacement on quality of life in patients with severe growth hormone deficiency
ea0011p573
Prolonged expression of the ACTH receptor, MC2-R, during 3T3-L1 adipocyte differentiation is dependent upon switching promoter usage to an adipocyte-specific, C/EBP-driven, downstream promoter
ea0011p574
Neuroendocrinology and behaviour
Association between the LRP5 gene and serum post-menopausal follicle stimulating hormone levels
ea0011p575
Structural analysis of somatotrophs and lactotrophs in annexin 1 null mice
ea0011p576
Dietary supplements for stress and obesity co-morbidities reduction
ea0011p577
The impact of hypothalamic-pituitary (h-p) irradiation on the TSH Bio/Immuno (B/I) ratio in the fed and fasting states
ea0011p578
Comparison of the catecholaminergic response to 2 different stressors in healthy men
ea0011p579
Effect of gastric bypass and gastric banding on neurotensin levels in morbidly obese patients
ea0011p580
Mental and neuropsychological disorders of children with congenital hypothyroidism
ea0011p581
Hypopituitary patients have a high occurrence of metabolic syndrome markers and an increased prevalence of cardiovascular risk factors
ea0011p582
Spontaneous GH secretion in the fed and fasting states in cranially irradiated adult cancer survivors with normal peak GH responses to two provocative tests: does GH neurosecretory dysfunction exist?
ea0011p583
The long-term predictive accuracy of the short synacthen (corticotropin) stimulation test for assessment of the hypothalamic-pituitary-adrenal axis
ea0011p584
GH secretion in amyotrophic lateral sclerosis
ea0011p585
Clinical significance of macroprolactin
ea0011p586
ADH and thirst function in defence with hypernatremia formation
ea0011p587
The effect of garlic odor on appetite center
ea0011p588
Taste protective mechanism in relation with salt
ea0011p589
The effect of salt on night sleep
ea0011p590
Evaluation of cognitive functions by using p300 auditory event related potentials (ERPs) in patients with growth hormone (GH) deficiency and gh excess
ea0011p591
Appetite regulating hormones in constitutionally lean and anorexia nervosa subjects
ea0011p592
Differentiation of TSH-oma from thyroid hormone resistance syndrome using thyroid color Doppler sonography
ea0011p593
Maternal consumption of a high-meat, low carbohydrate diet in late pregnancy and stress responsiveness in the offspring
ea0011p594
Patients with pituitary disease who have had radiotherapy have reduced cerebral vasomotor reactivity
ea0011p595
An open label, controlled study to assess the ability of patients with acromegaly, or their partners, to administer Somatuline Autogel
®
ea0011p596
The effect of dopamine on neuroendocrine disorders in women with PCOS under chronic stress conditions
ea0011p597
Measurement of basal cortisol in serum and saliva for the diagnosis of secondary adrenal insufficiency
ea0011p598
Sensitivity and specificity of different provocative tests for the diagnosis of secondary hypoadrenalism in patients with hypothalamo-pituitary disorders
ea0011p599
Pulmonary function in Cushings disease
ea0011p600
Adenosine stimulates connexin 43 expression and increases intercellular communication in the folliculostellate cells of the anterior pituitary gland
ea0011p601
Complement C5a inhibits the secretion of macrophage migration inhibitory factor (MIF) in anterior pituitary cell lines
ea0011p602
Unrecognized chronic hypopituitarism in patients who survived hemorrhagic fever with renal syndrome
ea0011p603
Ghrelin test for the assessment of growth hormone (GH) status in successfully treated patients with acromegaly
ea0011p604
The thickening of the pituitary stem In connection with 06 cases
ea0011p605
Effectiveness of the association of Bromocriptine and Cabergoline in the treatment of 05 invasif and giants prolactin macroadenoma
ea0011p606
Hypothalamic-pituitary dysfunction following irradiation of non-pituitary brain tumours in adults
ea0011p607
Bone mass and metabolism in active acromegaly no impact of gonadal status. a study of 73 patients
ea0011p608
Effect of pegvisomant on glucose metabolism
ea0011p609
Psychological and gastrointestinal problems in anorexia nervosa patients
ea0011p610
Octreotide shrinks the cellular rather than the vascular compartment in acromegalic tumours
in vivo
ea0011p611
Positive correlation between AcroQol and SF-36 and negative with BDI in sample of 60 acromegalics
ea0011p612
Quality of life (QoL) and psychiatric sequelae following aneurysmal subarachnoid hemorrhage (SAH): Does neuroendocrine dysfunction play a role?
ea0011p613
Pituitary function in patients with detectable serum pituitary autoantibodies
ea0011p614
Prevalence of pituitary autoantibodies in thyroid disorders
ea0011p615
Rate of change in size of macroprolactinomas with dopamine agonist therapy is there any relationship to fall in prolactin concentrations?
ea0011p616
The levels of ghrelin and leptin and body fat mass in patients treated for thyroid dysfunction
ea0011p617
Night sleep affected by salt
ea0011p618
ADH and Thirst Function in Defence with Hypernatremia Formation
ea0011p619
Taste protective mechanism in relation with salt
ea0011p620
Cushings syndrome as a model to investigate the effects on cognition of high circulating levels of glucocorticoid
ea0011p621
The influence of growth hormone replacement (GHR) in adults with GH deficiency (GHD) on body composition, basal metabolic rate, physical activity and ingestive behaviour
ea0011p622
Influence of affective changes on cortisol response to ACTH
ea0011p623
Interest of a single treatment by somatostatin analogues in a macroadenoma secreting TSH and GH
ea0011p624
Dehydroepiandrosterone (DHEA) improves psychological well-being in male and female hypopituitary patients in addition to growth hormone replacement (GHR)
ea0011p625
The influence of a GH receptor antagonist (GHRA) on the relationship between GH and IGF-I in adults with severe growth hormone deficiency (AGHD)
ea0011p626
Can adults with severe growth hormone deficiency (AsGHD) and a low IGF-I be distinguished from those with a normal IGF-I?
ea0011p627
Sleep disorders in acromegaly: preliminary data demonstrating a high prevalence of restless leg syndrome (RLS)
ea0011p628
Risk factors for the development of atherosclerosis in patients with acromegaly
ea0011p629
Microalbuminuria as well as insulin sensitivity are improved under octreotide-lar treatment in acromegalic patients
ea0011p630
Pro-opiomelanocortin and ACTH, precursors of alphaMSH, are secreted from human melanocytes and keratinocytes and can stimulate melanogenesis
ea0011p631
Processing and sorting of pro-opiomelanocortin is an important checkpoint in regulating release of ACTH from secretory vesicles in pituitary cells
ea0011p632
Hormone therapy effects on sleep and dreams in menopausal women
ea0011p633
Glucose-suppressed GH levels compared with IGF-I levels in patients with acromegaly
ea0011p634
Loss of rise in awakening cortisol response in prepubertal survivors of leukaemia post bone marrow transplantation and chemotherapy treatment
ea0011p635
The incidence of spontaneous cerebro-spinal fluid rhinorrhea in a large series of patients with macroprolactinoma
ea0011p636
Gonadotropin levels in the cerebrospinal fluid (CSF) as a marker of the gonadotropin secretion from non-functioning pituitary adenomas
ea0011p637
Prolonged post-operative follow-up is necessary for unirradiated non-functioning pituitary adenomata
ea0011p638
Anterior pituitary hormone dysfunction after traumatic brain injury: less common than previously thought?
ea0011p639
Effects of long-term GH treatment in Prader-Willi adults
ea0011p640
Endocrine abnormalities are common in transsexual individuals
ea0011p641
Glucagon-induced suppression of ghrelin secretion is exerted at hypothalamus-pituitary level and is not mediated by an increase in catecholamine secretion
ea0011p642
Complications of hormonal therapy in male to female transsexuals is uncommon
ea0011p643
Effects of targeted ablation of GHRH neurons in mice on anterior pituitary somatotrophs and lactotrophs
ea0011p644
Reproduction
Spermatogenesis in autologous testicular transplants in the non-human primate
Callithrix jacchus
ea0011p645
Hormonal status of women with benign endometrial hyperplastic lesions
ea0011p646
Dependence of semen characteristics on abstinence time, testicular volume and hormones
ea0011p647
Plasma endothelin-1 levels in patients with male hypogonadism
ea0011p648
Outcome of 59 pregnancies in 43 acromegalic women
ea0011p649
Difficulties in achieving
versus
maintaining erection: organic, psychogenic and relational determinants
ea0011p650
Psycho-biological correlates of smoking in patients with erectile dysfunction
ea0011p651
Psycho-biological correlates of delayed ejaculation in male patients with sexual dysfunctions
ea0011p652
Psycho-biological correlates of free-floating anxiety symptoms in male patients with sexual dysfunctions
ea0011p653
Histone deacetylase inhibitors exert estradiol-induced proliferation and hyperplasia formation in the mouse uterus
ea0011p654
Aetiologies of galactorrheas
ea0011p655
Standardisation and validation of a sensitive enzymeimmunoassay procedure to estimate 13,14-dihydro-15-keto-PGF
2α
(PGFM) in mithun (
Bos frontalis
) plasma
ea0011p656
Siofor efficacy in treatment of obesity and reproductive disorders
ea0011p657
Endothelin-1 levels in men of reproductive age with idiopathic hypogonadism after treatment with tamoxifen or raloxifene
ea0011p658
Clinical, hormonal, neuroradiological characteristics and response to treatment in 29 macroprolactinomas
ea0011p659
Prevalence of macroprolactinemia during pregnancy of women with prolactin-producing pituitary microadenomas
ea0011p660
Hormone replacement therapy in postmenopausis fails to normalize gonadotropins does it matter?
ea0011p661
All that is hypogonadal in haemochromatosis is not due to iron deposition
ea0011p662
Nitric-oxide-cGMP and ATP-cAMP pathways in pregnant women with gestational diabetes mellitus
ea0011p663
The influence of estradiol on erythrocyte antioxidative enzyme system activity in pre- and postmenopausal women
ea0011p666
The influence of the Cimicifuga Racemosa on the vegetovascular and psychoemotional disorders in women with climacteric syndrome
ea0011p667
Gonadal dysfunction in hypercortisolic men
ea0011p668
Role of estrogen receptor α- or β-isoforms in sex-specific brain organization
ea0011p669
An immortalised cell line (SK11) derived from immature mouse testes express functionally active androgen and oestrogen receptors
ea0011p670
Clinical and laboratory relationships in women with hirsutism as a primary symptom
ea0011p671
Bone mass density in 180 women with premature ovarian failure
ea0011p672
Oxidized low-density lipoprotein autoantibodies in patients with polycystic ovary syndrome
ea0011p673
Transforming growth factor beta 1 and decidualisation of the human endometrium
ea0011p674
Evidence for synergy of SHBG and androgen receptor genes in PCOS phenotype
ea0011p675
Factor analysis identifies three independent factors within PCOS
ea0011p676
Impaired vascular function in hypogonadal males is unaltered during monthly treatment cycle with intramuscular testosterone esters
ea0011p677
Changes in GnRH gene expression in the medial basal hypothalamus of rhesus macaques across the menstrual cycle
ea0011p678
Mechanisms of Wolffian duct differentiation; development of a model for studying androgen-driven stromal-epithelial interactions
ea0011p679
Neonatal, but not maternal, plasma lipid profiles are altered in pregnancy in women with polycystic ovarian syndrome (PCOS), compared with weight matched controls
ea0011p680
Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males
ea0011p681
Effect of chronic tadalafil administration on penile hypoxia induced by cavernous neurotomy in the rat
ea0011p682
Neuromedin U (NMU) and Neuromedin S (NMS) function as putative rregulators of the gonadotropic axis in the rat
ea0011p683
Circadian changes in melatonin secretion and its relationship to gonadotropins in premenopausal women
ea0011p684
Serum levels of PSA do not change in healthy pre-menopausal and in menopausal women, but are increased in subjects with polycystic ovary syndrome (PCOS)
ea0011p685
Expressions of KISS1 and GPR54 are differentially regulated by estradiol and GnRH in adult female rat pituitary
ea0011p686
Anti-Mullerian hormone (AMH) production by and amh type-II receptor (AMHRII) in normal human ovaries
ea0011p687
Identification and functional study of a new FSH receptor gene mutation in women affected by polycystic ovary syndrome (PCOS)
ea0011p688
Plasma kisspeptin is a novel tumour marker in patients with gestational trophoblastic neoplasia
ea0011p689
Chronic subcutaneous administration of kisspeptin-54 causes testicular degeneration in adult male rats
ea0011p690
Oxidative stress, endothelial function, and arterial stiffness in young patients with polycystic ovary syndrome
ea0011p691
Aldosterone and renin plasma levels in young patients with polycystic ovary syndrome
ea0011p692
Association between polymorphisms within the SUR1/Kir6.2 gene region and polycystic ovary syndrome: a case-control study
ea0011p693
Effect of family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome
ea0011p694
A review of cimetidine (tagamet) effects as a reoproductive toxicant in male rats prostate and seminal vesicle
ea0011p695
A review of male rat genital system morphology followed cimetidine injection
ea0011p696
A review of cimetidine (tagamet) effects as a reoproductive toxicant in male rats leydig cells
ea0011p697
Functional restoration of intact rabbit ovary after cryopreservation and transplantation
ea0011p698
Effects of metformin therapy in lean subjects with pcos on insulin resistance indices
ea0011p699
Comparison of various insulin sensivity indices in idiopathic hirsutism
ea0011p700
Metformin therapy decreases hyperandrogenism and hyperinsulinaemia in women with polycystic ovary syndrome
ea0011p701
A unique subgroup of patients with polycystic ovary syndrome identified by clinical and biochemical features
ea0011p702
Obstetric hazards of maternal obesity
ea0011p703
Cardiopulmonary impairment in young women with polycystic ovary syndrome
ea0011p704
Metformin decreases CRP level and cardiovascular risk in PCOS women
ea0011p705
Functional characterization of the follicle-stimulating hormone receptor core promoter: applying a comparative approach among primates
ea0011p706
Testosterone restores diabetes-induced erectile dysfunction and sildenafil responsiveness in two distinct animal models of chemical diabetes
ea0011p707
Androgenic status is influenced by AR polymorphism (CAG repeats number)
ea0011p708
Role of D327N sex-hormone binding globulin gene polymorphism in the pathogenesis of polycystic ovary syndrome
ea0011p709
Endocrine evaluation of a large cohort of male cancer survivors compared with healthy controls
ea0011p710
The use of prolonged human chorionic gonadotrophin stimulation testing in the evaluation of undescended testes
ea0011p711
Stage-specific mRNA expression of androgen receptor correlated with FSH receptor in individual pre-antral follicles isolated from human ovary
ea0011p712
Hyperprolactinaemia due to big prolactin
ea0011p713
Efficacy of Testogel in the treatment of hypogonadism in routine clinical practice
ea0011p714
Which clinical features of polycystic ovary syndrome are improved with metformin therapy? A retrospective study
ea0011p715
Comparison of Insulin Resistance levels in pre and post-menopausal women, women with polycystic ovarian syndrome and postmenopausal women with Type 2 Diabetes
ea0011p716
11β-hydroxysteroid dehydrogenase (11βHSD) activities in porcine granulosa cells from ovarian follicles and cysts
ea0011p717
Secretion of adiponectin by human placenta: differential modulation by cytokines
ea0011p718
Functionality of largest follicles is affected in gonadotrophin-stimulated cycles
ea0011p719
Screening for gene SRY by FISH in patients with Turner Syndrome
ea0011p720
Serum Anti-Mullerian hormone (AMH) concentrations in infants and children
ea0011p721
Prenatal diagnosis of P450 oxidoreductase deficiency
ea0011p722
Isolated progesterone secretion by an ovarian Leydig cell tumour: I, hormonal and immunohistochemical characterization II, effects on the gonadotrope axis
ea0011p723
Serum inhibin levels in patients with polycystic ovary syndrome
ea0011p724
Outcomes of pregnancy and glycaemic control in patients with type 1 diabetes
ea0011p725
Characteristic changes of skin and its accessories in relation to diabetic peripheral neuropathy in patients with type 2 diabetes mellitus
ea0011p726
Steroids
High risk of adrenal insufficiency after single intra- or peri-articular steroid administration in young healthy sportsmen
ea0011p727
Capillary blood, an alternative to saliva for the diagnosis of Cushings syndrome?
ea0011p728
Gonadal dysfunction in male hypercortisolic subjects
ea0011p729
A ras recruitment screen for glucocorticoid receptor-interacting proteins using the entire receptor as bait
ea0011p730
Hormones of cortex of adrenal glands in patients after cardiac arrest in early postresuscitation period
ea0011p731
Clinical presentation of a patient with novel mutation in CYP17 gene
ea0011p732
Hypothalamic-pituitary-adrenal axis in diabetes: role of autonomic unbalance
ea0011p733
Establishing circadian rhythm profiles for salivary testosterone in women: evidence of decline during ageing
ea0011p734
Prevalence of classical forms of 21-hydroxylase deficiency in Western Siberia according to the results of neonatal screening of congenital adrenal hyperplasia
ea0011p735
The New Zealand White Albino Rabbit is a suitable model for the evaluation of 11β-hydroxysteroid dehydrogenase type 1 activity in ocular tissues
ea0011p736
Androgen status in women with hypogonadotropic hypogonadism
ea0011p737
Long-term glucocorticoid repression of pro-opiomelanocortin (
POMC
) expression
ea0011p738
A novel CYP11B2 gene mutation in an Asian family with aldosterone synthase deficiency
ea0011p739
Long-term effect of flutamide, metformin and their combination in dieting obese women with polycystic ovary syndrome
ea0011p740
Can the 250mcg synacthen test be used to screen for primary hyperaldosteronism?
ea0011p741
The functional consequences of local glucocorticoid metabolism in synovial fibroblasts
ea0011p742
Challenges in paediatric Cushings disease
ea0011p743
Endogenous corticosteroid synthesis in subjects after bilateral adrenalectomy
ea0011p744
Tissue specific regulation of insulin signalling: a mechanism of glucocorticoid induced obesity?
ea0011p745